Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
posTErs<br />
Posters<br />
CliniCAl TrACK: lUnG<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 208 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
> Radiotherapy versus radiochemotherapy in patients with favorable<br />
prognosis stage III nonsmall-cell lung cancer<br />
B. Jeremic (Serbia), B. Milicic, S. Milisavljevic PO-0738<br />
> Induction chemotherapy plus concurrent chemoradiotherapy (CRT)<br />
vs CRT in the unresectable stage III NSCLC<br />
J.H. Chang (Korea Republic of), S.H. Moon, K.H. Cho, T.H. Kim,<br />
H.J. Kim, H.G. Wu PO-0739<br />
> Individualised dose prescription for hypofractionation in advanced<br />
NSCLC radiotherapy: an in silico trial<br />
A.L. Hoffmann (The Netherlands), E.G.C. Troost, H. Huizenga,<br />
J.H.A.M. Kaanders, J. Bussink PO-0740<br />
> Postoperative radiotherapy for incompletely resected (R1) nonsmall<br />
cell lung cancer: a retrospective review<br />
M. Olszyna-Serementa (Poland), J. Socha, M. Wierzchowski,<br />
L. Kepka PO-0741<br />
> Reirradiation for locally recurrent lung cancer in patients previously<br />
treated with radiation therapy (RT)<br />
V. Chicata Sutmöller (Spain), C. Eito Valdovinos, M. Vila Viñas,<br />
E. Martínez López, M. Rico Osés, A. Sola Galarza,<br />
M.A. Domínguez Domínguez PO-0742<br />
> EGFR TKIs combined with definite radiotherapy for stage IV<br />
non-small cell lung cancer with bone-only metastases<br />
Q. Pang (China), P. Wang, J. Wang, L. Zhao, Z. Yuan, W. Wang,<br />
J. Sun, H. Hou PO-0743<br />
> Is 14 day mortality a useful measure of palliative radiotherapy<br />
efficacy in lung cancer<br />
K. Gupta (United Kingdom), C. Faivre-Finn, P. Burt, A. Chittalia,<br />
M. Harris, L. Lee, L. Pemberton, H. Sheikh, P. Higham, N. Bayman PO-0744<br />
Posters<br />
abS. numbER<br />
> Can FDG PET during the course of radiation therapy for lung cancer<br />
predict for esophagitis and pneumonitis outcome?<br />
P. McCloskey (Canada), V. Ford, J. Bissonnette, J. Higgins,<br />
K. Clarke, N. Becker, C. Leavens, A. Bezjak, A. Hope, A. Sun PO-0745<br />
> Prognostic factors in stereotactic body radiotherapy for<br />
non-small-cell lung cancer<br />
Y. Kosaka (Japan), M. Kokubo, H. Nishimura, N. Ueki PO-0746<br />
> Radical radiotherapy for non small cell lung cancer using two<br />
different modalities: single centre audit outcome<br />
D. Srinivasan (United Kingdom), S. Garikipati, M. Hatton,<br />
J. Lester, P.M. Fisher, C. Lee, J. Mohanamurali, T. Das, L. Hatton PO-0747<br />
> Sensitivity of textural and shape features in CT images to tumor<br />
definition<br />
S. Carvalho (The Netherlands), E. Rios Velazquez, R. Leijenaar,<br />
H. Aerts, D. De Ruysscher, P. Lambin PO-0748<br />
> Metabolism of adeno- and squamous cell lung carcinomas:<br />
consequences for survival and treatment<br />
T.W.H. Meijer (The Netherlands), O.C.J. Schuurbiers, P.N. Span,<br />
J.H.A.M. Kaanders, J. Bussink PO-0749<br />
> Mature results of a phase 2 dose-escalation study in unresectable,<br />
locally advanced non-small cell lung cancer<br />
C. Collen (Belgium), D. Schallier, M. Meysman, L. Van Moorter,<br />
S. Bral, H. Everaert, D. Verdries, M. De Ridder PO-0750<br />
> Lung toxicity and survival in radical radiotherapy of stage III<br />
non-small-cell lung cancer<br />
K.P. Farr (Denmark), A.A. Khalil, M.M. Knap, C. Grau PO-0751<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 209<br />
posTErs<br />
eSTRO 31
Change language